This inventor holds 13 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Vrije Universiteit Brussel, Bac IP B.v., Conopco, Inc.. Active years: 1998-2010.
Company Filing History:
10 out of 190 
1 out of 6 
1 out of 1,591 
Years Active: 1998-2010
Title: Innovations and Contributions of Inventor Raymond Hamers
Introduction
Raymond Hamers is a notable inventor based in Sint-Genesius-Rode, Belgium. He has made significant contributions to the field of biotechnology, particularly in the production of antibodies derived from camelidae. With a total of 13 patents to his name, Hamers has established himself as a key figure in his area of expertise.
Latest Patents
One of Hamers' latest patents focuses on the production of antibodies or functionalized fragments derived from heavy chain immunoglobulins of camelidae. This innovative process utilizes a transformed lower eukaryotic host containing a DNA sequence that encodes the antibody or its fragments. The resulting antibodies are devoid of light chains and can be produced using molds or yeasts. Additionally, the heavy chain fragment can include the entire variable domain, allowing for the grafting of complementary determining regions (CDRs) that differ from those of natural camelidae antibodies. Another significant patent involves methods for screening a library of VHH polypeptides for those that bind to specific antigens, enhancing the efficiency of antibody development.
Career Highlights
Throughout his career, Hamers has worked with esteemed institutions such as Vrije Universiteit Brussel and Conopco, Inc. His work has not only advanced scientific understanding but has also led to practical applications in the field of immunology.
Collaborations
Hamers has collaborated with notable individuals in his field, including Cecile Casterman and Cecile Hamers-Casterman. These partnerships have contributed to the success of his research and innovations.
Conclusion
Raymond Hamers is a distinguished inventor whose work in antibody production and biotechnology has made a lasting impact. His patents and collaborations reflect his commitment to advancing science and technology in meaningful ways.